Genus PLC Completion of acquisition (0814J)

TIDMGNS

RNS Number : 0814J

Genus PLC

01 April 2015

For Immediate Release 1 April 2015

Genus plc

Completion of the acquisition of 51% of In Vitro Brasil S.A.

Genus plc ("Genus"), a leading global animal genetics company, is pleased to confirm that, further to the announcement on 16 February 2015, it has now completed the acquisition of 51% of In Vitro Brasil S.A. ("IVB"), a leading biotechnology company focused on the production of bovine embryos through in-vitro fertilisation ("IVF") and the provision of associated services.

IVB represents an excellent strategic fit with Genus's core activities and is expected to strengthen Genus's global leadership in the development and delivery of differentiated genetics in the beef and dairy sectors through the introduction of IVF technology.

- End -

For further information please contact:

 
Genus plc                               Tel: 01256 345970 
Karim Bitar, Chief Executive Officer 
Stephen Wilson, Group Finance Director 
 
Buchanan                                Tel: 0207 466 5000 
Charles Ryland 
 Sophie McNulty

This announcement is available on the Genus website www.genusplc.com

About Genus

Genus creates advances to animal breeding and genetic improvement by applying biotechnology and sells added value products for livestock farming and food producers. Its technology is applicable across all livestock species and is currently commercialised by Genus in the dairy, beef and pork food production sectors.

Genus's worldwide sales are made in seventy-five countries under the trademarks "ABS" (dairy and beef cattle) and "PIC" (pigs) and comprise semen and breeding animals with superior genetics to those animals currently in production. Genus's customers' animals produce offspring with greater production efficiency, and quality, and use these to supply the global dairy and meat supply chain.

Genus's competitive edge has been created from the ownership and control of proprietary lines of breeding animals, the biotechnology used to improve them and its global supply chain, technical service and sales and distribution network.

With headquarters in Basingstoke, United Kingdom, Genus companies operate in over twenty-five countries on six continents, with research laboratories located in Madison, Wisconsin, USA.

About IVB

IVB is the world's leading provider of IVF and associated services to the livestock industry.

IVB was founded in 2002 to meet the growing demand for bovine IVF services. Today IVB produces in excess of 250,000 bovine embryos annually. IVB is headquartered in Mogi Mirim, Brazil, and operates through wholly owned laboratories, joint ventures and franchise agreements.

This information is provided by RNS

The company news service from the London Stock Exchange

END

ACQJBMFTMBAJBIA

Genus (LSE:GNS)
Historical Stock Chart
From Jun 2024 to Jul 2024